Cidara Therapeutics Stock Price History
| CDTX Stock | USD 23.10 0.35 1.54% |
Below is the normalized historical share price chart for Cidara Therapeutics extending back to April 14, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cidara Therapeutics stands at 23.10, as last reported on the 20th of March, with the highest price reaching 23.49 and the lowest price hitting 22.28 during the day.
If you're considering investing in Cidara Stock, it is important to understand the factors that can impact its price. At this stage we consider Cidara Stock to be not too volatile. Cidara Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0201, which signifies that the company had a 0.0201 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Cidara Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Cidara Therapeutics' risk adjusted performance of 0.0361, and Mean Deviation of 3.41 to double-check if the risk estimate we provide is consistent with the expected return of 0.0884%.
At this time, Cidara Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 6.7 M in 2025, whereas Common Stock is likely to drop 950.00 in 2025. . At this time, Cidara Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 1.10 in 2025, whereas Price Earnings Ratio is likely to drop (1.06) in 2025. Cidara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of April 2015 | 200 Day MA 16.0713 | 50 Day MA 22.0254 | Beta 0.878 |
Cidara |
Sharpe Ratio = 0.0201
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | CDTX | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.39 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Cidara Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cidara Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.5259 | Enterprise Value Ebitda (1.64) | Price Sales 195.4448 | Shares Float 4.6 M | Wall Street Target Price 36.6 |
Cidara Therapeutics Stock Price History Chart
There are several ways to analyze Cidara Stock price data. The simplest method is using a basic Cidara candlestick price chart, which shows Cidara Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 2, 2025 | 27.3 |
| Lowest Price | January 29, 2025 | 17.85 |
Cidara Therapeutics March 20, 2025 Stock Price Synopsis
Various analyses of Cidara Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cidara Stock. It can be used to describe the percentage change in the price of Cidara Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cidara Stock.| Cidara Therapeutics Price Rate Of Daily Change | 1.02 | |
| Cidara Therapeutics Price Action Indicator | 0.39 | |
| Cidara Therapeutics Price Daily Balance Of Power | 0.29 | |
| Cidara Therapeutics Accumulation Distribution | 42,075 |
Cidara Therapeutics March 20, 2025 Stock Price Analysis
Cidara Stock Price History Data
The price series of Cidara Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 9.45 with a coefficient of variation of 9.45. The prices are distributed with arithmetic mean of 22.41. The median price for the last 90 days is 22.38. The company had 1:20 stock split on 24th of April 2024.| Open | High | Low | Close | Volume | ||
| 03/20/2025 | 22.28 | 23.49 | 22.28 | 23.10 | 816,820 | |
| 03/19/2025 | 22.84 | 23.22 | 22.04 | 22.75 | 188,792 | |
| 03/18/2025 | 22.27 | 23.25 | 21.91 | 22.75 | 82,483 | |
| 03/17/2025 | 22.45 | 22.59 | 21.30 | 22.27 | 90,681 | |
| 03/14/2025 | 22.31 | 22.70 | 22.04 | 22.05 | 60,726 | |
| 03/13/2025 | 23.15 | 23.44 | 21.76 | 22.36 | 84,965 | |
| 03/12/2025 | 21.92 | 23.66 | 21.00 | 23.00 | 148,656 | |
| 03/11/2025 | 21.96 | 21.96 | 20.15 | 21.00 | 126,939 | |
| 03/10/2025 | 24.14 | 24.14 | 21.78 | 22.39 | 106,453 | |
| 03/07/2025 | 21.85 | 23.94 | 21.85 | 23.66 | 52,851 | |
| 03/06/2025 | 23.37 | 24.00 | 23.11 | 23.61 | 51,232 | |
| 03/05/2025 | 22.96 | 23.64 | 22.62 | 23.50 | 51,437 | |
| 03/04/2025 | 22.56 | 24.00 | 22.28 | 23.16 | 98,042 | |
| 03/03/2025 | 24.86 | 25.78 | 23.02 | 23.05 | 150,161 | |
| 02/28/2025 | 23.75 | 25.24 | 23.16 | 24.90 | 257,214 | |
| 02/27/2025 | 22.11 | 24.14 | 21.82 | 23.85 | 61,488 | |
| 02/26/2025 | 21.53 | 22.59 | 21.42 | 22.13 | 102,609 | |
| 02/25/2025 | 20.47 | 22.16 | 20.11 | 21.42 | 105,739 | |
| 02/24/2025 | 21.50 | 21.52 | 19.96 | 20.50 | 71,067 | |
| 02/21/2025 | 22.29 | 22.30 | 21.23 | 21.54 | 51,838 | |
| 02/20/2025 | 23.40 | 23.40 | 20.50 | 22.38 | 84,259 | |
| 02/19/2025 | 23.94 | 24.95 | 23.40 | 23.81 | 168,700 | |
| 02/18/2025 | 23.88 | 24.32 | 23.60 | 24.00 | 86,507 | |
| 02/14/2025 | 23.22 | 24.30 | 22.34 | 23.94 | 106,444 | |
| 02/13/2025 | 23.00 | 24.99 | 22.80 | 23.33 | 126,608 | |
| 02/12/2025 | 21.74 | 24.81 | 21.74 | 23.47 | 125,686 | |
| 02/11/2025 | 21.50 | 22.93 | 21.15 | 21.99 | 40,532 | |
| 02/10/2025 | 21.70 | 22.62 | 21.49 | 21.73 | 79,034 | |
| 02/07/2025 | 21.38 | 21.94 | 21.06 | 21.68 | 157,418 | |
| 02/06/2025 | 20.00 | 21.39 | 19.72 | 21.23 | 77,258 | |
| 02/05/2025 | 20.19 | 21.46 | 20.19 | 20.22 | 35,016 | |
| 02/04/2025 | 18.87 | 20.29 | 18.76 | 20.04 | 168,755 | |
| 02/03/2025 | 18.33 | 19.50 | 18.04 | 18.95 | 134,306 | |
| 01/31/2025 | 18.07 | 19.00 | 17.92 | 18.58 | 77,170 | |
| 01/30/2025 | 17.65 | 18.12 | 17.17 | 18.10 | 72,545 | |
| 01/29/2025 | 18.81 | 18.81 | 17.68 | 17.85 | 31,708 | |
| 01/28/2025 | 17.97 | 19.24 | 17.59 | 18.92 | 74,074 | |
| 01/27/2025 | 19.02 | 19.28 | 18.11 | 18.12 | 51,459 | |
| 01/24/2025 | 21.59 | 21.60 | 18.57 | 18.91 | 72,892 | |
| 01/23/2025 | 21.90 | 22.65 | 21.55 | 21.80 | 147,984 | |
| 01/22/2025 | 22.00 | 22.22 | 21.63 | 21.99 | 125,219 | |
| 01/21/2025 | 21.90 | 22.68 | 21.64 | 22.18 | 82,675 | |
| 01/17/2025 | 21.04 | 22.00 | 20.76 | 21.70 | 229,225 | |
| 01/16/2025 | 20.42 | 21.80 | 20.26 | 21.25 | 113,494 | |
| 01/15/2025 | 21.09 | 21.92 | 19.87 | 20.42 | 93,217 | |
| 01/14/2025 | 21.02 | 22.35 | 20.82 | 20.92 | 74,828 | |
| 01/13/2025 | 23.94 | 24.39 | 21.11 | 21.19 | 95,052 | |
| 01/10/2025 | 24.79 | 25.45 | 22.50 | 24.00 | 136,361 | |
| 01/08/2025 | 27.60 | 27.60 | 21.50 | 24.88 | 231,579 | |
| 01/07/2025 | 27.12 | 27.70 | 26.12 | 27.00 | 234,061 | |
| 01/06/2025 | 26.57 | 27.00 | 25.11 | 26.81 | 171,468 | |
| 01/03/2025 | 27.30 | 27.69 | 25.41 | 26.62 | 118,544 | |
| 01/02/2025 | 27.11 | 28.42 | 26.01 | 27.30 | 134,338 | |
| 12/31/2024 | 25.61 | 27.44 | 25.11 | 26.88 | 183,549 | |
| 12/30/2024 | 23.99 | 25.32 | 23.26 | 25.25 | 116,886 | |
| 12/27/2024 | 23.44 | 24.25 | 22.85 | 23.69 | 134,433 | |
| 12/26/2024 | 23.20 | 23.42 | 22.70 | 23.22 | 49,538 | |
| 12/24/2024 | 23.26 | 23.70 | 22.63 | 23.43 | 31,947 | |
| 12/23/2024 | 22.90 | 24.31 | 21.88 | 23.40 | 75,044 | |
| 12/20/2024 | 22.12 | 24.00 | 21.20 | 23.22 | 148,362 | |
| 12/19/2024 | 20.49 | 23.21 | 20.24 | 22.51 | 85,919 |
About Cidara Therapeutics Stock history
Cidara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cidara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cidara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cidara Therapeutics stock prices may prove useful in developing a viable investing in Cidara Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 6.3 M | 6.7 M | |
| Net Loss | -26.8 M | -28.2 M |
Cidara Therapeutics Stock Technical Analysis
Cidara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
Cidara Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cidara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cidara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cidara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0361 | |||
| Jensen Alpha | 0.1238 | |||
| Total Risk Alpha | 0.5249 | |||
| Sortino Ratio | 0.0381 | |||
| Treynor Ratio | (0.85) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cidara Stock Analysis
When running Cidara Therapeutics' price analysis, check to measure Cidara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cidara Therapeutics is operating at the current time. Most of Cidara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cidara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cidara Therapeutics' price. Additionally, you may evaluate how the addition of Cidara Therapeutics to your portfolios can decrease your overall portfolio volatility.